6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
30m ago	First Stoping Operations at Perseus Mining's CMA Underground
56m ago	Elanco's Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock
56m ago	Sally Beauty Holdings Announces Conference Call and Webcast to Discuss Second Quarter Financial Results on May 11, 2026
56m ago	CBRE Group, Inc. Announces Pricing of $750 Million Senior Notes due 2036
57m ago	LifeStance Health Group Set to Join S&P SmallCap 600

About

Replimune Group Inc (NASDAQ:REPL) — investor relations, events, news, and company updates on 6ix.

Latest News

Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference

Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)

Financials

Revenue

$0

Market Cap

$694.44 M

EPS

-3.44

Community Chat

Ask AI